Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
1,699.62
1,526.28
1,156.25
1,978.54
1,686.64
1,173.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,699.62
1,526.28
1,156.25
1,978.54
1,686.64
1,173.55
Raw Material Cost
985.17
995.15
608.06
1,256.76
1,120.55
643.85
Purchase of Finished goods
26.70
17.06
16.30
16.95
12.80
15.20
(Increase) / Decrease In Stocks
12.84
-60.06
148.81
-100.01
-158.18
-34.74
Employee Cost
103.48
84.67
87.30
97.88
87.42
77.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
414.71
412.18
318.07
443.82
379.32
224.52
Total Expenditure (Excl Depreciation)
1,542.89
1,449.01
1,178.54
1,715.41
1,441.91
925.86
Operating Profit (PBDIT) excl Other Income
156.73
77.27
-22.29
263.13
244.73
247.69
Other Income
59.18
30.00
28.74
87.44
69.64
6.53
Operating Profit (PBDIT)
215.91
107.27
6.45
350.57
314.37
254.22
Interest
71.38
49.69
43.87
49.98
2.60
20.33
Exceptional Items
0.00
0.00
0.00
0.00
6.11
6.50
Gross Profit (PBDT)
144.53
57.58
-37.42
300.59
317.88
240.39
Depreciation
89.62
78.65
69.43
54.48
45.23
36.92
Profit Before Tax
54.90
-21.08
-106.86
246.10
272.65
203.47
Tax
34.19
9.34
-18.80
62.54
70.44
53.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.71
-30.42
-88.07
183.56
202.21
150.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.71
-30.42
-88.07
183.56
202.21
150.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.71
-30.42
-88.07
183.56
202.21
150.45
Equity Capital
25.43
25.43
25.43
25.43
25.43
25.43
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
-0.14
-0.17
-1.5
0.33
2.69
2.2
Operating Profit Margin (Excl OI)
9.22%
5.06%
-1.93%
13.3%
14.51%
21.11%
Gross Profit Margin
8.5%
3.77%
-3.24%
15.19%
18.85%
20.48%
PAT Margin
1.22%
-1.99%
-7.62%
9.28%
11.99%
12.82%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 11.36% vs 32.00% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 168.08% vs 65.46% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 102.83% vs 446.66% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 43.65% vs 13.27% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Meghmani Organi. With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
1,699.62
821.24
878.38
106.96%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,699.62
821.24
878.38
106.96%
Raw Material Cost
985.17
467.58
517.59
110.70%
Purchase of Finished goods
26.70
2.10
24.60
1,171.43%
(Increase) / Decrease In Stocks
12.84
41.87
-29.03
-69.33%
Employee Cost
103.48
75.64
27.84
36.81%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
414.71
143.88
270.83
188.23%
Total Expenditure (Excl Depreciation)
1,542.89
731.07
811.82
111.05%
Operating Profit (PBDIT) excl Other Income
156.73
90.17
66.56
73.82%
Other Income
59.18
11.79
47.39
401.95%
Operating Profit (PBDIT)
215.91
101.96
113.95
111.76%
Interest
71.38
11.82
59.56
503.89%
Exceptional Items
0.00
-2.08
2.08
100.00%
Gross Profit (PBDT)
144.53
88.06
56.47
64.13%
Depreciation
89.62
19.95
69.67
349.22%
Profit Before Tax
54.90
68.11
-13.21
-19.40%
Tax
34.19
15.13
19.06
125.97%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
20.71
52.98
-32.27
-60.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
20.71
52.98
-32.27
-60.91%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.71
52.98
-32.27
-60.91%
Equity Capital
25.43
12.26
13.17
107.42%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
8.50%
10.72%
0.00
-2.22%
PAT Margin
1.22%
6.45%
0.00
-5.23%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,699.62 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 11.36% vs 32.00% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 20.71 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 168.08% vs 65.46% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 156.73 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 102.83% vs 446.66% in Dec 2024
Nine Monthly - Interest
Interest 71.38 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 43.65% vs 13.27% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.22%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024






